References
- Lamm DL, Stogdill VD, Stogdill BJ, Crispen RG. Complications of bacillus Calmette-Guerin immunotherapy in 1278 patients with bladder cancer. J Urol 1986; 135: 272–4
- Lamm DL, van der Meijden PM, Morales A, Brosman SA, Catalona WJ, Herr HW, et al. Incidence and treatment of complications of bacillus Calmette-Guérin intravesical therapy in superficial bladder cancer. J Urol 1992; 147: 596–600
- Morales A. Long-term results and complications of intracavitary bacillus Calmette-Guérin therapy for bladder cancer. J Urol 1984; 132: 457–9
- Steg A, Sicard D, Leleu C, DeBre B, Boccon-Gibod L. Systemic complications of intravesical BCG therapy for bladder cancer. Lancet 1985; 2: 899
- Steg A, Leleu C, DeBre B, Boccon-Gibod L, Sicard D. Systemic BCG infection, ‘BCGitis’ in patient treated by intravesical BCG therapy for bladder cancer. J Eur Urol 1989; 16: 161–4
- Lamm DL. Complications of bacillus Calmette-Guérin immunotherapy. Urol Clin North Am 1992; 19: 565–72
- Prescott S, Jacksom AM, Hawkyard SJ, Alexandroff AB, James K. Mechanisms of action of intravesical bacillus Calmette-Guérin: local immune mechanisms. Clin Infect Dis 2000; 31: S91–3
- Bast RC, Jr, Zbar B, Borsos T, Rapp HJ. BCG and cancer. N Engl J Med 1974; 290: 1413–20
- Durand JM, Roubcek C, Retornaz F, Cretel E, Payan MJ, Bernard JP, Kaplanski G, Soubeyrand J. Cryoglobulinemia after intravesical administration of Bacille Calmette-Guérin. Clin Infect Dis 1998; 26: 497–8
- Saporta L, Gumus E, Karadag H, Kuran B, Miroglu C. Reiter syndrome following intracavitary BCG administration. Scand J Urol Nephrol 1997; 31: 211–2
- Han BG, Choi SO, Shin SJ, Kim HY, Jung SH, Lee KH. A case of Henoch-Schönlein purpura in disseminated tuberculosis. Korean J Intern Med 1995; 10: 54–9
- Islek I, Muslu A, Totan M, Gok F, Sanic A. Henoch-Schönlein purpura and pulmonary tuberculosis. Pediatr Int 2002; 44: 545–6
- Yano S. Henoch-Schonlein purpura associated with pulmonary Mycobacterium avium-intracellulare complex. Intern Med 2004; 43: 843–5
- Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, Janecek E, Domecq C, Greenblatt DJ. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981; 30: 239–45